Wednesday, January 12, 2022: Life Sciences

Medicare officials said the program should restrict coverage of Aduhelm, Biogen’s Alzheimer’s drug, to patients participating in randomized, controlled clinical trials. The agency made its decision after reviewing scientific evidence and various stakeholder opinions...

Wednesday, January 12, 2022: Life Sciences

The federal government ordered another 600,000 doses of GlaxoSmithKline PLC and Vir Biotechnology Inc.’s monoclonal antibody treatment for COVID-19. The drugmakers plan to deliver the treatment, which is the only one thought to work against the Omicron variant,...